Alcohol use and metabolic syndrome are highly prevalent in the population and frequently
co-exist. Both are implicated in a large range of health problems, including chronic liver …

The obesity epidemic is closely associated with the rising prevalence and severity of
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …

Nonalcoholic fatty liver disease (NAFLD) and alcohol-related liver disease (ALD) are the
leading causes of chronic liver disease worldwide. NAFLD and ALD share …

Cigarette smoking is a preventable risk factor for premature morbidity and mortality. A history
of smoking is observed in approximately 40% of patients with liver disease, while a growing …

Recently, international expert panels have proposed a new definition of fatty liver: metabolic
dysfunction‐associated fatty liver disease (MAFLD). MAFLD is not just a simple renaming of …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide, with a prevalence of 25–30%. Since its first description in 1980, NAFLD has …

Evidence on liver injury and non-alcoholic fatty liver disease (NAFLD) from volatile organic
compounds (VOCs) exposure is insufficient. A cross-sectional study including 3011 US …

Background and Aims The effects of alcohol use in nonalcoholic fatty liver disease are
unclear. We investigated the impact of alcohol use in fatty liver disease on incident liver …

Background & Aims Non-alcoholic and alcohol-related fatty liver disease are overlapping
diseases in which metabolic syndrome and alcohol consumption each contribute to …